Medigene (MDG1) Stock Statistics & Valuation Metrics

Medigene has a market cap or net worth of €372.19K. The enterprise value is -$3.76M.

Medigene has 14,887,594 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medigene’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -61.87%.

The current PE Ratio of Medigene is ―. Medigene’s PEG ratio is -0.03.

In the last 12 months, Medigene had revenue of 6.03M and earned -16.18M in profits. Earnings per share was -1.25.

In the last 12 months, operating cash flow was -14.17M and capital expenditures -621.00K, giving a free cash flow of -14.79M billion.

Medigene pays an annual dividend of ―, resulting in a dividend yield of ―

Medigene upcoming earnings date is Nov 13, 2025, TBA (Confirmed).

Medigene as a current ratio of 2.53, with Debt / Equity ratio of 14.00%

In the past 12 months, Medigene has paid -415.00K in taxes.

Medigene EV to EBITDA ratio is -2.26, with an EV/FCF ratio of -2.09.

Medigene has €14.02M in cash and marketable securities with €2.54M in debt, giving a net cash position of €11.48M billion.

Gross margin is 72.77%, with operating margin of -267.63%, and net profit margin of -268.10%.

The average price target for Medigene is ―, which is 11.43% higher than the current price. The consensus rating is ―